Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.51 |
| ▸ | TSHR | P16473 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | CA12 | O43570 | 2/20 | 0.45 |
| ▸ | CA1 | P00915 | 2/20 | 0.45 |
| ▸ | CA2 | P00918 | 2/20 | 0.45 |
| ▸ | CA9 | Q16790 | 2/20 | 0.45 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.45 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 2/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31042998 | 1.00 | KMT2A (0.51) | KMT2AKDM4ETSHRALDH1A1MEN1 | |
| SCHEMBL5099244 | 0.86 | KMT2A (0.47) | KMT2AKDM4ETSHRALDH1A1MEN1 | |
| SCHEMBL1554320 | 0.86 | KDM4E (0.53) | KDM4ETSHRALDH1A1MAPTPOLB | |
| SCHEMBL15056307 | 0.84 | KDM4E (0.44) | KMT2AKDM4ETSHRALDH1A1MEN1 | |
| SCHEMBL2060569 | 0.84 | KDM4E (0.44) | KMT2AKDM4ETSHRALDH1A1MEN1 | |
| SCHEMBL265432 | 0.82 | CTBP2 (0.51) | KMT2AKDM4ETSHRALDH1A1MEN1 | |
| SCHEMBL30522283 | 0.82 | CTBP2 (0.51) | KMT2AKDM4ETSHRALDH1A1MEN1 | |
| SCHEMBL5903219 | 0.82 | KDM4E (0.43) | KMT2AKDM4ETSHRALDH1A1MEN1 | |
| SCHEMBL286702 | 0.82 | KMT2A (0.48) | KMT2AKDM4ETSHRALDH1A1MEN1 | |
| SCHEMBL31284578 | 0.82 | KDM4E (0.43) | KMT2AKDM4ETSHRALDH1A1MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 562 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117756834-A | Synthesis method of 2- (aminocarbonylmethyl) phenylboronic acid pinacol ester | 大连双硼医药化工有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-116003682-B | Acrylonitrile copolymer and preparation method and application thereof | 山西钢科碳材料有限公司 | 2024-03-01 | — | — | CN | claimed |
| CN-116606400-A | Wastewater treatment agent and preparation method thereof | 山东诺尔生物科技有限公司 | 2023-08-18 | — | — | CN | claimed |
| CN-116003682-A | Acrylonitrile copolymer and preparation method and application thereof | 山西钢科碳材料有限公司 | 2023-04-25 | — | — | CN | claimed |
| CN-108047072-A | A kind of synthetic method of C14H10Cl2NNaO2 | 深圳华中科技大学研究院 | 2018-05-18 | — | — | CN | claimed |
| CN-107793323-A | A kind of synthetic method of Diclofenac methyl esters | 华中科技大学 | 2018-03-13 | — | — | CN | claimed |
| CN-101659719-B | Room-temperature self-repairing type thermoplastic polymer material and preparation method thereof | UNIV SUN YAT SEN | 2011-03-30 | — | — | CN | claimed |
| CN-101659719-A | Room-temperature self-repairing type thermoplastic polymer material and preparation method thereof | UNIV SUN YAT SEN | 2010-03-03 | — | — | CN | claimed |
| WO-2001062803-A2 | SUPPORTED CATALYSTS FOR USE IN ATOM TRANSFER RADICAL POLYMERIZATION AND CONTINUOUS PROCESSES FOR ATOM TRANSFER RADICAL POLYMERIZATION | MCMASTER UNIVERSITY (CA) | 2001-08-30 | — | — | WO | claimed |
| US-12606549-B2 | Anticholinergic agents | REZUBIO PHARMACEUTICALS CO., LTD (CN) | 2026-04-21 | — | — | US | disclosed |
| US-20260078130-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | SIRONAX LTD (KY) | 2026-03-19 | — | — | US | disclosed |
| EP-4692057-A1 | NOVEL B0AT1 INHIBITOR | Mitsubishi Tanabe Pharma Corporation (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260035335-A1 | PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF | RELAY THERAPEUTICS INC (US) | 2026-02-05 | — | — | US | disclosed |
| US-20260001849-A1 | NOVEL B0AT1 INHIBITOR | MITSUBISHI TANABE PHARMA CORPORATION (JP) | 2026-01-01 | — | — | US | disclosed |
| WO-1991011999-A1 | ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT | MERCK & CO., INC. (US) | 1991-08-22 | — | — | WO | disclosed |
| WO-1991012001-A1 | ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT | MERCK & CO., INC. (US) | 1991-08-22 | — | — | WO | disclosed |
| WO-1991012002-A1 | IMIDAZOLE ANGIOTENSIN II ANTAGONISTS INCORPORATING A SUBSTITUTED BENZYL ELEMENT | MERCK & CO., INC. (US) | 1991-08-22 | — | — | WO | disclosed |
| US-4937374-A | Process for preparing methyl 3-methoxy-2-(2-phenoxyphenyl)propenoalis | IMPERIAL CHEMICAL INDUSTRIES PLC (GB) | 1990-06-26 | — | — | US | disclosed |
| CN-1031840-A | Benzofuran derivative and preparation method thereof | TANABE SEIYAKU CO (JP) | 1989-03-22 | — | — | CN | disclosed |
| US-4723031-A | Processes for synthesizing substituted and unsubstituted aminoacetate esters | CHEVRON RESEARCH COMPANY (US) | 1988-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260001849-A1 | NOVEL B0AT1 INHIBITOR | BCAT1, BCAT2, BHMT | KMT2A 433/4885KDM4E 3501/4885TSHR 1492/4885 |
| US-20260078130-A1 | NAMPT MODULATORS, PREPARATIONS, AND USES THEREOF | NAMPT, NNMT, SARM1 | KMT2A 2737/4885KDM4E 3382/4885TSHR 363/4885 |
| US-12606549-B2 | Anticholinergic agents | CHRM1, CHRNA1, CHRND | KMT2A 2414/4885KDM4E 3010/4885TSHR 54/4885 |
| US-20260035335-A1 | PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF | PIK3CD, PIK3CG, PIK3CB | KMT2A 3086/4885KDM4E 1916/4885TSHR 3475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.